年齢とアルツハイマー病

Neuropathological Evidence of Reduced Amyloid Beta and Neurofibrillary Tangles in Multiple Sclerosis Cortex.

Annals of neurology·2025

Investigating virtual reality navigation in amnestic mild cognitive impairment using fMRI.

Neuropsychology, development, and cognition. Section B, Aging, neuropsychology and cognition·2015

Alterations in working memory networks in amnestic mild cognitive impairment.

Neuropsychology, development, and cognition. Section B, Aging, neuropsychology and cognition·2014

Differences in cognitive profile between TIA, stroke and elderly memory research subjects: a comparison of the MMSE and MoCA.

Cerebrovascular diseases (Basel, Switzerland)·2012

Neuropathology of the hippocampus in FTLD-Tau with Pick bodies: a study of the BrainNet Europe Consortium.

Neuropathology and applied neurobiology·2012

Neuropathologic evidence of endothelial changes in cerebral small vessel disease.

Neurology·2011

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Reliability and validity study of the Turkish form of the Temporal Experience of Pleasure Scale (TEPS-TR).

Dusunen adam : Bakirkoy Ruh ve Sinir Hastaliklari Hastanesi yayin organi·2026

Outcomes of transforaminal lumbar interbody fusion in a working-age population (≤50 years): a propensity score-matched cohort study.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia·2026

Higher amyloid deposition and lower white matter volume in cognitively healthy seniors exceeding French alcohol recommendations.

EBioMedicine·2026

Differential Effects of Age and Simulated Sensory-Motor Constraints on Digit Symbol Substitution Test Performance.

Experimental aging research·2026

Delta-9-tetrahydrocannabinol delineates D-galactose and aluminium chloride-induced cognitive dysfunction and neurodegeneration in the hippocampus of the Wistar rat model.

Journal of biosciences·2026

Determinants of advance-directive completion for end-of-life preparedness among older Korean adults.

Frontiers in public health·2026

関連する実験動画

年齢とアルツハイマー病

関連する概念動画

Neuropathological Evidence of Reduced Amyloid Beta and Neurofibrillary Tangles in Multiple Sclerosis Cortex.

Investigating virtual reality navigation in amnestic mild cognitive impairment using fMRI.

Alterations in working memory networks in amnestic mild cognitive impairment.

Differences in cognitive profile between TIA, stroke and elderly memory research subjects: a comparison of the MMSE and MoCA.

Neuropathology of the hippocampus in FTLD-Tau with Pick bodies: a study of the BrainNet Europe Consortium.

Neuropathologic evidence of endothelial changes in cerebral small vessel disease.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Reliability and validity study of the Turkish form of the Temporal Experience of Pleasure Scale (TEPS-TR).

Outcomes of transforaminal lumbar interbody fusion in a working-age population (≤50 years): a propensity score-matched cohort study.

Higher amyloid deposition and lower white matter volume in cognitively healthy seniors exceeding French alcohol recommendations.

Differential Effects of Age and Simulated Sensory-Motor Constraints on Digit Symbol Substitution Test Performance.

Delta-9-tetrahydrocannabinol delineates D-galactose and aluminium chloride-induced cognitive dysfunction and neurodegeneration in the hippocampus of the Wistar rat model.

Determinants of advance-directive completion for end-of-life preparedness among older Korean adults.

関連する実験動画

年齢とアルツハイマー病

関連する概念動画

関連記事